A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
2020 ◽
Vol 150
◽
pp. 275-280
◽
Keyword(s):
2020 ◽
Vol 108
(3)
◽
pp. e873-e874